Clinical trial landscape for histone deacetylation inhibitors in breast cancer: a dawn in the darkness?

Clinical trial landscape for histone deacetylation inhibitors in breast cancer: a dawn in the darkness?

Saved in:

Bibliographic Details
Main Authors:	Jiajun Li, Yining Yan, Feng Chen
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-024-05911-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Histone deacetylation inhibitors affect in vitro oocyte maturation and somatic cell nuclear transfer in pigs
by: Phitchanika Pankammoon, et al.
Published: (2024-10-01)

Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring
by: Jizhen Li, et al.
Published: (2025-08-01)

Histone deacetylation as a landmark for Sgo2 relocation from centromeres to subtelomeres during interphase
by: Miho Osaki, et al.
Published: (2025-06-01)

The role of acetylation and deacetylation in cancer metabolism
by: Cuicui Wang, et al.
Published: (2025-01-01)

Sepsis and ARDS: The Dark Side of Histones
by: Zhiheng Xu, et al.
Published: (2015-01-01)

Histone acetylation modulators in breast cancer
by: Xueying Yuan, et al.
Published: (2025-03-01)

Factor XI and XII inhibitors–Dawn of a new era
by: Chhabi Satpathy, et al.
Published: (2025-03-01)

The dawn of urbanity
by: Lidia Decandia, et al.
Published: (2025-07-01)

Landscape of Histone Posttranslational Modifications in Osteoarthritis
by: Zhao S, et al.
Published: (2025-06-01)

Histone Signatures Predict Therapeutic Efficacy in Breast Cancer
by: Shamim A. Mollah, et al.
Published: (2020-01-01)

Acetylation‐Deacetylation‐Driven Natural Product Biosynthesis
by: Huibin Wang, et al.
Published: (2025-07-01)

The influence of chitin structure on its enzymatic deacetylation
by: Jaworska Malgorzata M., et al.
Published: (2016-06-01)

Dust at the Cosmic Dawn
by: Yuri A. Shchekinov, et al.
Published: (2025-05-01)

Dancing at the Dawn of Agriculture
by: Serdar Özbilen
Published: (2024-06-01)

Interview with Dawn Raffel
by: Monica Manolescu-Oancea
Published: (2011-04-01)

The dawn of spatiotemporal transcriptomics
by: Siying Wang, et al.
Published: (2024-06-01)

The Dawn of European Civilization /
by: Childe, V. Gordon (Vere Gordon), 1892-1957
Published: (1957)

A journey from darkness to dawn: Metaphoric variation in depression recovery stories posted on Chinese Wechat subscription accounts
by: Lin Lin, et al.
Published: (2025-06-01)

Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon
by: A. V. Vitebskaya, et al.
Published: (2021-11-01)

Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study
by: Beate Vajen, et al.
Published: (2025-05-01)

A New Dawn of the East?
by: S. M. Markedonov
Published: (2021-08-01)

George Gissing, Workers in the Dawn
by: Christine Huguet
Published: (2010-12-01)

The Dawn of Statistical ASR and MT
by: Frederick Jelinek
Published: (2021-03-01)

The functional interactome landscape of the human histone deacetylase family
by: Preeti Joshi, et al.
Published: (2013-06-01)

Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions
by: Mohammed Alrouji, et al.
Published: (2024-11-01)

Fn14 Controls the SIRT2‐Mediated Deacetylation of Slug to Inhibit the Metastasis of Epithelial Ovarian Cancer
by: Anyue Wu, et al.
Published: (2025-07-01)

dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation
by: Mohammad Mijanur Rahman, et al.
Published: (2024-12-01)

SIRT6 deficiency impairs the deacetylation and ubiquitination of UHRF1 to strengthen glycolysis and lactate secretion in bladder cancer
by: Xiaojing Wang, et al.
Published: (2024-12-01)

HDAC3-mediated deacetylation of p21 stabilizes protein levels and promotes 5-FU resistance in colorectal cancer cells
by: Wei Jin, et al.
Published: (2025-06-01)

SAP30 deacetylates the Tas protein to inhibit PFV replication
by: Chenchen Wang, et al.
Published: (2025-04-01)

Mechanisms of resistance to histone deacetylase inhibitors in acute leukemia
by: Mohammad Amin Akbarzadeh, et al.
Published: (2024-12-01)

A new dawn for ticket regulation?
by: Guy Osborn, et al.
Published: (2024-04-01)

The journal: The dawn of a new era
by: Gboyega A. Ogunbanjo
Published: (2012-04-01)

Dawn Raffel–A Family Portrait
by: Monica Manolescu-Oancea
Published: (2011-04-01)

AI Agents and the Dawn of Post-Authenticity
by: Octavian Dumitru HERA
Published: (2025-04-01)

Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?
by: Fernanda Faião-Flores, et al.
Published: (2019-12-01)

Structural and Material Properties of Chitin Nanofibers Produced Without Deacetylation Treatment
by: Yuka Tomita, et al.
Published: (2025-08-01)

Proline cis-trans isomerization is influenced by local lysine acetylation-deacetylation
by: Françoise S. Howe, et al.
Published: (2014-10-01)

Using the software «DAWN AC» for control of dosing warfarin in the special anticoagulation clinics
by: O. S. Napalkova, et al.
Published: (2015-06-01)

Corrigendum to “Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer” [Neoplasia. 2014 Aug;16(8):665-77]
by: Tao Zhang, et al.
Published: (2025-07-01)